Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

Sakharkar, M. K., Shashni, B., Sharma, K., Dhillon, S. K., Ranjekar, P. R., & Sakharkar, K. R. (2013). Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer. PPAR Research, 2013(), 5-15. https://doi.org/10.1155/2013/109285
Chang, Y. Y. (2015). Molecular Characterization of Triple-negative Breast Cancer [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2015.02600
Amos, K. D., Adamo, B., & Anders, C. K. (2012). Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials. International Journal of Breast Cancer, 2012(), 117-123. https://doi.org/10.1155/2012/385978
Teijido, P. G., Cabal, M. L., Fernández, I. P., & Pérez, Y. F. (2016). Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting. Clinical Medicine Insights: Oncology, (), 31-39. https://doi.org/10.4137/CMO.S34540
Gucalp, A., & Traina, T. A. (2011). Triple-Negative Breast Cancer: Adjuvant Therapeutic Options. Chemotherapy Research and Practice, 2011(), 104-116. https://doi.org/10.1155/2011/696208